Prima·Derm, S.L.

Prima·Derm, S.L. is a Spanish molecular cosmetics startup founded in 2008 by esteemed chemist Dr. García Antón, renowned for developing Argireline® and SNAP®, the pioneering anti-wrinkle peptides with a botox-like effect. The company's deep commitment to skincare is evident in its dermocosmetic products based on scientific innovation, created through thorough research and analysis to address the needs of patients, skin professionals, and distributors. Prima·Derm excels in developing and controlling every aspect of its formulas, from creating proprietary active ingredients such as peptides, growth factors, and biotechnological extracts to novel delivery systems in its in-house laboratory. This allows for the introduction of the highest concentrations of active ingredients, ensuring efficacy and results. Notably, the company's brand Singuladerm has emerged as a leader in molecular and preventive cosmetics, effectively translating pharmaceutical science into dermocosmetics. Prima·Derm's expertise extends across E-Commerce and Manufacturing, setting it apart as an innovator in the cosmetics industry, with potential for substantial growth and investment opportunities.